imaGenes GmbH Adds Third Roche NimbleGen Certification to Service Portfolio for CGH
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
Roche NimbleGen has announce that imaGenes GmbH, located in Berlin, Germany, has passed the certification process to qualify as a Roche NimbleGen Certified Service Provider (CSP) for Comparative Genomic Hybridization (CGH).
imaGenes is a solution provider for functional genomics and proteomics with a comprehensive portfolio of high-quality services for molecular life sciences. This is the third Roche NimbleGen certification for imaGenes to provide service for NimbleGen arrays. This follows the certification for ChIP-chip in December 2009 and DNA methylation analysis in February 2010, and makes imaGenes the first service provider in Europe with the CGH certification.
With this announcement, imaGenes now offers CGH using the comprehensive array workflow from Roche NimbleGen, which includes the NimbleGen MS 200 Microarray Scanner, arrays, reagents and software.
“The comprehensive portfolio of Roche NimbleGen certified services enables imaGenes to offer any functional DNA analysis to its customers in consistent high quality. Roche NimbleGen is our reliable partner en route to become the premier service provider for both biomarker development and clinical research applications,” says Dr. Johannes Maurer, Director Genomic Products & Marketing at imaGenes.
imaGenes is a solution provider for functional genomics and proteomics with a comprehensive portfolio of high-quality services for molecular life sciences. This is the third Roche NimbleGen certification for imaGenes to provide service for NimbleGen arrays. This follows the certification for ChIP-chip in December 2009 and DNA methylation analysis in February 2010, and makes imaGenes the first service provider in Europe with the CGH certification.
With this announcement, imaGenes now offers CGH using the comprehensive array workflow from Roche NimbleGen, which includes the NimbleGen MS 200 Microarray Scanner, arrays, reagents and software.
“The comprehensive portfolio of Roche NimbleGen certified services enables imaGenes to offer any functional DNA analysis to its customers in consistent high quality. Roche NimbleGen is our reliable partner en route to become the premier service provider for both biomarker development and clinical research applications,” says Dr. Johannes Maurer, Director Genomic Products & Marketing at imaGenes.
